Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 1 of 1 for:    CX839-012
Previous Study | Return to List | Next Study

A Study of Telaglenastat (CB-839) in Combination With Palbociclib in Patients With Solid Tumors

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03965845
Recruitment Status : Completed
First Posted : May 29, 2019
Last Update Posted : October 29, 2021
Sponsor:
Information provided by (Responsible Party):
Calithera Biosciences, Inc

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 24, 2021
Actual Study Completion Date : September 24, 2021